The transaction is part of our strategy to lower interest expense, reduce dilution, and significantly extend debt maturityOffering priced at ...

BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of 0.75% convertible senior notes ...

Investing.com -- BridgeBio Pharma has priced a private offering of $550 million in convertible senior notes due 2033, with a 0.75% interest rate and a 45% conversion premium.

Compass ( COMP) said it priced an $850 million private offering of convertible senior notes due 2031, up $100 million from ...

Compass, Inc. (NYSE: COMP) (the "Company"), today announced the pricing of its offering of $850.0 million in aggregate principal amount of convertible senior notes due 2031 (the "Notes") in a private ...

TV ( (FUBO)) has provided an update. On January 7, 2026, FuboTV Inc. announced that no holders of its Convertible Senior Secured Notes due 2029 elected to tender their notes for repurchase following ...

$1.15 billion 0.00% Convertible Senior Notes offering (27.50% conversion premium) The repurchase of approximately $460 million of the common stock from investors in the Convertible Notes CleanSpark ...

Super Micro Computer (NASDAQ:SMCI) announced Tuesday that it has priced the $2 billion convertible senior notes due 2030. The stock recovered some losses Tuesday after a 9.7% fall on Monday, when the ...

Xometry, Inc. announced the successful closing of a $250 million offering of convertible notes due in 2030, aimed at refinancing existing debt and improving financial flexibility. The company intends ...